GlassScriptPhysician profile
Abel Cabrera-Martinez
NPI 1780066670
$1,100.92
in general payments reported to CMS, 2019-2025
9 companies · $388 in 2025
The $388 reported for 2025 was less than what a typical Cornea and External Diseases Specialist provider received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $49.54 · 2021: $20.63 · 2022: $23.43 · 2023: $22.96 · 2024: $95.33 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $446.28 | 2019-2021 | |
| Alcon Vision LLC | $223.83 | 2024-2025 | Clareon, Simbrinza, Hydrus Microstent |
| Novartis Pharmaceuticals Corporation | $125.00 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $92.99 | 2025 | Xdemvy |
| Abbvie INC. | $87.44 | 2023-2025 | Alphagan P, Vuity, Lumigan |
| Mallinckrodt Hospital Products INC. | $52.38 | 2025 | Acthar |
| Dompe US, INC. | $27.14 | 2024 | Oxervate |
| Biotissue Holdings INC. | $23.43 | 2022 | |
| New World Medical,INC. | $22.43 | 2025 | Via360, Ahmed Glaucoma Valve, Kahook Dual Blade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abel Cabrera-Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.